Evaluate the Safety and Efficacy of TRG-200 KIT in Patients With Refractory Overactive Bladder.
Evaluate the Safety and Efficacy of TRG-200 KIT in Patients With Refractory Overactive Bladder.
Not yet recruiting · NCT07391878 · Registry updated 2026-02-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluate the Safety and Efficacy of TRG-200 KIT in Patients With Refractory Overactive Bladder. | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, Male Urogenital Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, Urological Manifestations, overactive bladder, urinary bladder disorder, urinary system disorder | Not yet recruiting | Phase 2 | 2026-02-06 | NCT07391878 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Trigone Pharma Ltd. | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shaare Zedek Medical Center | Jerusalem | Israel | 78 |